Greystone Financial Group LLC Sells 93 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Greystone Financial Group LLC cut its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.9% in the first quarter, Holdings Channel reports. The fund owned 844 shares of the company’s stock after selling 93 shares during the quarter. Greystone Financial Group LLC’s holdings in HCA Healthcare were worth $292,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in HCA. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC bought a new position in shares of HCA Healthcare in the 4th quarter worth $36,000. Activest Wealth Management boosted its position in HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after purchasing an additional 125 shares in the last quarter. Legacy Investment Solutions LLC raised its holdings in HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock worth $62,000 after purchasing an additional 95 shares in the last quarter. Finally, Physician Wealth Advisors Inc. bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $64,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Up 0.8%

HCA Healthcare stock opened at $384.52 on Monday. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The business has a 50 day simple moving average of $355.28 and a 200-day simple moving average of $331.71. The stock has a market capitalization of $92.51 billion, a PE ratio of 17.50, a price-to-earnings-growth ratio of 1.10 and a beta of 1.49. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same period in the previous year, the business earned $5.36 EPS. HCA Healthcare’s quarterly revenue was up 5.7% on a year-over-year basis. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.75%. HCA Healthcare’s dividend payout ratio is presently 12.81%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. Stephens raised HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Barclays set a $416.00 price target on shares of HCA Healthcare and gave the stock an “overweight” rating in a report on Monday, June 2nd. Royal Bank of Canada reduced their target price on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Robert W. Baird restated a “neutral” rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Finally, Wall Street Zen raised shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, April 28th. Seven analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $388.80.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.